WallStreetZenWallStreetZen

NASDAQ: INCY
Incyte Corp Stock Ownership - Who owns Incyte?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Incyte Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Paul J. ClancyDirector2025-03-31358$60.55
$21.68kBuy
Edmund HarriganDirector2025-03-31363$60.55
$21.98kBuy
Matteo TrottaEVP GM Dermatology US2025-03-25537$62.08
$33.34kSell
Barry P. FlannellyEVP General Manager US2025-03-14199$67.88
$13.51kSell
Barry P. FlannellyEVP General Manager US2025-03-14461$67.85
$31.28kSell
Barry P. FlannellyEVP General Manager US2025-03-1419,147$67.68
$1.30MSell
Sheila A. DentonEVP General Counsel2025-03-04599$69.99
$41.92kSell
Sheila A. DentonEVP General Counsel2025-03-04599$58.06
$34.78kBuy
Sheila A. DentonEVP General Counsel2025-02-264,495$74.08
$332.99kSell
Sheila A. DentonEVP General Counsel2025-02-269,574$58.06
$555.87kBuy

1 of 7

INCY insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when INCY insiders and whales buy or sell their stock.

INCY Shareholders

What type of owners hold Incyte Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Baker Bros Advisors LP15.88%30,739,466$1.86BInstitution
Julian Baker10.26%19,851,744$1.20BInsider
Vanguard Group Inc10.12%19,580,477$1.18BInstitution
Blackrock Inc8.53%16,510,467$997.73MInstitution
Dodge Cox7.71%14,919,633$901.59MInstitution
Baker Brothers Life Sciences LP6.43%12,445,783$752.10MInsider
Baker Brothers Life Sciences Capital GP LLC6.42%12,430,783$751.19MInsider
State Street Corp5.18%10,031,136$606.18MInstitution
Baker Biotech Capital GP LLC2.54%4,911,003$296.77MInsider
Renaissance Technologies LLC2.11%4,085,932$246.91MInstitution

1 of 3

INCY vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INCY76.18%23.82%Net SellingNet Selling
BMRN95.98%1.72%Net SellingNet Selling
INSM83.58%16.42%Net SellingNet Selling
MRNA71.65%22.83%Net SellingNet Buying
EXEL89.31%5.19%Net SellingNet Selling
View Top Biotech Stocks

Incyte Stock Ownership FAQ

Who owns Incyte?

Incyte (NASDAQ: INCY) is owned by 94.18% institutional shareholders, 29.45% Incyte insiders, and 0.00% retail investors. Julian Baker is the largest individual Incyte shareholder, owning 19.85M shares representing 10.26% of the company. Julian Baker's Incyte shares are currently valued at $1.24B.

If you're new to stock investing, here's how to buy Incyte stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.